FATE
Fate Therapeutics Inc
Price:  
1.19 
USD
Volume:  
1,996,286.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FATE Fair Value

-744.67 %
Upside

What is the fair value of FATE?

As of 2025-06-23, the Fair Value of Fate Therapeutics Inc (FATE) is -7.67 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.19 USD, the upside of Fate Therapeutics Inc is -744.67%.

Is FATE a good investment?

With the market price of 1.19 USD and our fair value calculation, Fate Therapeutics Inc (FATE) is not a good investment. Investing in FATE stocks now will result in a potential loss of 744.67%.

Note: valuation result may not be accurate due to the company's negative EPS.

1.19 USD
Stock Price
-7.67 USD
Fair Price
FAIR VALUE CALCULATION

FATE Fair Value

Peter Lynch's formula is:

FATE Fair Value
= Earnings Growth Rate x TTM EPS
FATE Fair Value
= 5.00 x -1.53
FATE Fair Value
= -7.67

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income -173.39 -212.15 -281.72 -160.93 -186.26 -202.89
YoY growth -76.66% -22.35% -32.79% 42.88% -15.74% -20.93%

FATE Fair Value - Key Data

Market Cap (mil) 136.41
P/E
Forward P/E
EPS -1.53
Avg earnings growth rate -20.93%
TTM earnings -175.88